PVLA Palvella Therapeutics, Inc.

bullish · high conviction track record → $123.59 -3.46 (-2.7%)
Get emailed when PVLA changes direction
Mkt Cap $2B 52wk $20.20 - $151.18 Earnings 2026-05-14 3h ago
Insider selling: $2,602,545 sold by 4 insiders (30d)
Est. revisions: -5.0% (3 up, 4 down in 30d)
Backed by structured data (insider trades, analyst ratings, or filings)
Factor Model (net -1.3)

Factor Model

net -1.3 4.4 / 10
Est. Revisions
-0.3
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
-0.3
Narrative Gap
-0.5

PVLA short interest falls 9% to 1.98M

Watch: Monitor the FDA New Drug Application submission timing in H2 2026 for impact on approval and share momentum.

Short interest in Palvella Therapeutics dropped 9.1% to 1,978,927 shares, representing 16.0% of the float. Days to cover stands at 7.3, indicating moderate short covering. This follows recent positive Phase 3 trial results and a bullish market stance.

Reduced short interest suggests growing investor confidence in Palvella's regulatory and commercial prospects, supporting its near-term FDA approval path.

Evidence

5h ago Short interest dropped 9% to 1,978,927 shares
14d ago Insider buy by JENKINS GEORGE M (PVLA): $49,974
14d ago Insider buy by JENKINS GEORGE M (PVLA): $500,000
14d ago Insider buy by HERON ELAINE J (PVLA): $300,000
14d ago Insider buy by JENKINS GEORGE M (PVLA): $100,797
14d ago Insider buy by JENKINS GEORGE M (PVLA): $51,720
14d ago Insider buy by ADAR1 CAPITAL MANAGEMENT LLC (PVLA): $92,326
2 older signals
Fundamentals & Data ▾
Palvella Therapeutics, Inc. Healthcare · Biotechnology
Mkt Cap
$2B
52w Range
$20.20 - $151.18
Short Interest
2.0M 16.04%
Days to Cover
7.3 +3%
Technicals downtrend
from 52w Hi
-5.4%
1w return
-4.9%
Insiders
mixed 6B / 6S
EPS Estimate
$-0.93 -5.0% 30d 3up / 4dn
Est. Dispersion
41% 11 analysts
Analyst Target
$230 $205 - $270
Options P/C
0.05
Insider Cluster
strong buy 3B / 1S
Recent Filings & Data
insider trade 13
net selling · $2,602,545 sold · $1,094,817 bought
4 insiders · 13 transactions (30d)
Recent transactions
JENKINS GEORGE M · buy · $49,974
GOIN KATHLEEN · sell · $507,611
GOIN KATHLEEN · exercise · $34,883
JENKINS GEORGE M · buy · $500,000
HERON ELAINE J · buy · $300,000
GOIN KATHLEEN · sell · $341,564
GOIN KATHLEEN · sell · $419,983
GOIN KATHLEEN · sell · $415,023
GOIN KATHLEEN · sell · $370,965
JENKINS GEORGE M · buy · $100,797
JENKINS GEORGE M · buy · $51,720
ADAR1 CAPITAL MANAGEMENT LLC · buy · $92,326
GOIN KATHLEEN · sell · $547,399
10 signals · latest 5h ago

Get alerted when PVLA changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.